Clinical Trial Update: A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

View source ↗

Summary

This clinical trial proposes a fast diffusion-weighted MRI protocol to surveil patients at high risk of ovarian cancer recurrence who are on PARP-inhibitor main…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Carcinoma

Drugs mentioned

• PARP inhibitors (maintenance) (PARP inhibitor)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Ovarian Cancer, Recurrent Ovarian Carcinoma | Status: NOT_YET_RECRUITING